Positive News SentimentPositive NewsNASDAQ:NNNN Anbio Biotechnology (NNNN) Stock Price, News & Analysis $3.80 -0.25 (-6.17%) Closing price 11/12/2026 04:00 PM EasternExtended Trading$3.82 +0.02 (+0.53%) As of 11/12/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC FilingsShort Interest About Anbio Biotechnology Stock (NASDAQ:NNNN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Anbio Biotechnology alerts:Sign Up Key Stats Today's Range$3.80▼$3.9650-Day Range$3.13▼$6.6052-Week Range$3.09▼$44.73Volume15,515 shsAverage Volume54,782 shsMarket Capitalization$546.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Anbio Biotechnology is a medical technology company focused on in vitro diagnostic products used to detect and monitor health conditions. Its offerings include diagnostic testing systems and related products designed for clinical and point-of-care settings. The company’s product portfolio includes testing equipment and diagnostic reagents, supporting the analysis of patient samples. These tools are intended to help healthcare providers obtain test results outside or alongside conventional laboratory workflows. Publicly available information about Anbio’s history, leadership, and geographic reach is limited, so those details are not included here.AI Generated. May Contain Errors. Read More Anbio Biotechnology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreNNNN MarketRank™: 0.837470603605 of 5 starsAnbio Biotechnology scored higher than 17% of companies evaluated by MarketBeat, and ranked 833rd out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingAnbio Biotechnology has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAnbio Biotechnology has only been the subject of 1 research reports in the past 90 days.Read more about Anbio Biotechnology's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioAnbio Biotechnology has a P/B Ratio of 18.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.02% of the float of Anbio Biotechnology has been sold short.Short Interest Ratio / Days to CoverAnbio Biotechnology has a short interest ratio ("days to cover") of 0.55, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Anbio Biotechnology has recently increased by 6.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAnbio Biotechnology does not currently pay a dividend.Dividend GrowthAnbio Biotechnology does not have a long track record of dividend growth. News and Social Media3.0 / 5News SentimentN/A News SentimentAnbio Biotechnology has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Anbio Biotechnology this week, compared to 1 article on an average week. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Anbio Biotechnology insiders have not sold or bought any company stock.Percentage Held by InstitutionsAnbio Biotechnology has minimal institutional ownership at this time.Read more about Anbio Biotechnology's insider trading history. Receive NNNN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Anbio Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NNNN Stock News HeadlinesTop 3 Health Care Stocks You'll Regret Missing In Q2June 18, 2026 | benzinga.comAnbio Biotechnology Shareholders Approve Sweeping Capital and Governance ChangesMay 19, 2026 | tipranks.comUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it. | Digest Publishing (Ad)Anbio Biotechnology Calls May 15 Shareholder Votes on Sweeping Capital and Governance OverhaulApril 27, 2026 | tipranks.comAnbio Biotechnology Posts Solid FY25 Results, Diversifies PortfolioApril 9, 2026 | benzinga.comAnbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing UpMarch 3, 2026 | seekingalpha.comAnbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting TimelineFebruary 17, 2026 | tipranks.comSee More Headlines NNNN Stock Analysis - Frequently Asked Questions How have NNNN shares performed this year? Anbio Biotechnology's stock was trading at $21.51 on January 27, 2026. Since then, NNNN shares have decreased by 82.3% and is now trading at $3.80. When did Anbio Biotechnology IPO? Anbio Biotechnology (NNNN) raised $9 million in an initial public offering on Wednesday, February 19th 2025. The company issued 1,600,000 shares at a price of $5.00-$6.00 per share. Who are Anbio Biotechnology's major shareholders? Top institutional investors of Anbio Biotechnology include State Street Corp (0.02%). How do I buy shares of Anbio Biotechnology? Shares of NNNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NNNN's financial health is in the Yellow zone, according to TradeSmith. NNNN has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NNNN CIK1982708 Webwww.anbio.com Phone4916096247281FaxN/AEmployees27Year Founded2021Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$8.65 million Price / Sales63.21 Cash Flow$0.04 per share Price / Cash Flow91.00 Book Value$0.21 per share Price / Book18.10Miscellaneous Outstanding Shares143,890,000Free FloatN/AMarket Cap$546.78 million OptionableN/A Beta5.72 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:NNNN) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anbio Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share Anbio Biotechnology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
